P. Cordopatis

发表

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.

J. Reubi, B. Nock, T. Maina, 2005, Journal of medicinal chemistry.

The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway

W. Sessa, A. Papapetropoulos, A. Pyriochou, 2007, Journal of cellular physiology.

Exploring the Potential of Natural Products in Cancer Treatment

P. Cordopatis, F. Lamari, 2008 .

Inhibition of breast cancer cell proliferation by style constituents of different Crocus species.

N. Karamanos, P. Cordopatis, F. Lamari, 2007, Anticancer research.

Synthesis, liposomal formulation and thermal effects on phospholipid bilayers of leuprolide

T. Mavromoustakos, C. Demetzos, S. Hatziantoniou, 2006, Journal of peptide science : an official publication of the European Peptide Society.

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

G. Loudos, E. Chiotellis, B. Nock, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.

R. Moncayo, C. Decristoforo, B. Nock, 2004, Cancer biotherapy & radiopharmaceuticals.

99mTc-Demotate 1: first data in tumour patients—results of a pilot/phase I study

R. Moncayo, C. Decristoforo, B. Nock, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.

E. Krenning, M. de Jong, J. Reubi, 2014, European journal of medicinal chemistry.

[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

E. Krenning, M. de Jong, J. Reubi, 2012, EJNMMI Research.

Synthesis and sst2 binding profiles of new [Tyr3]octreotate analogs

B. Nock, T. Maina, A. Nikolopoulou, 2008, Journal of peptide science : an official publication of the European Peptide Society.

Natural Products in Cancer Treatment

P. Cordopatis, F. Lamari, 2008 .

[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate

B. Bernard, E. Krenning, M. Jong, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Carotid Atherosclerosis in Type 2 Diabetes Mellitus: Potential Role of Endothelin-1, Lipoperoxides, and Prostacyclin

D. Mikhailidis, P. Cordopatis, I. Migdalis, 2002, Angiology.

Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study

P. Cordopatis, J. Slaninová, V. Magafa, 2010, Amino Acids.

Synthesis and biological evaluation of oxytocin analogues containing l-α-t-butylglycine [Gly(Bu t )] in positions 8 or 9

P. Cordopatis, M. Fragiadaki, J. Slaninová, 2003, Peptides.

A new validated SPE-HPLC method for monitoring crocetin in human plasma--application after saffron tea consumption.

C. Georgakopoulos, P. Cordopatis, F. Lamari, 2011, Journal of pharmaceutical and biomedical analysis.

Metal complexes of dipeptides containing the α-aminoisobutyric residue (Aib): preparation, characterization and crystal structures of copper(II) complexes with H–Aib–Aib–OH

A. Terzis, C. Raptopoulou, D. Raptis, 2002 .

Convenient synthesis of n-trityl-o-alkyl-l-hydroxyamino acids and derivatives : Application to the synthesis of related peptides

P. Cordopatis, D. Papaioannou, K. Barlos, 1983 .

Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production

W. Koch, A. Lymperopoulos, G. Rengo, 2016, Pharmacology research & perspectives.

Fast atom bombardment mass spectrometry of malic acid analogues of angiotensin II.

A. Furst, T. Lee, P. Cordopatis, 1983, Biochemical and biophysical research communications.

Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin

E. Papadimitriou, P. Cordopatis, J. Courty, 2012, Vascular cell.

Monitoring the structural consequences of Phe12-->D-Phe and Leu15-->Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists.

G. Spyroulias, P. Cordopatis, G. Pairas, 2001, European journal of biochemistry.

The Thyroxine-Containing Thyroglobulin Peptide (aa 2549–2560) Is a Target Epitope in Iodide-Accelerated Spontaneous Autoimmune Thyroiditis

P. Cordopatis, P. Georghiou, S. Rahman, 2014, The Journal of Immunology.

Autoimmune Thyroiditis Iodide-Accelerated Spontaneous 2560) Is a Target Epitope in - Peptide (aa 2549 The Thyroxine-Containing Thyroglobulin

P. Cordopatis, P. Georghiou, S. Rahman, 2014 .

[99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results

B. Nock, T. Maina, A. Nikolopoulou, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection

Maria Tsachaki, P. Cordopatis, F. Lamari, 2011, Behavioural Brain Research.

In position 7 l- and d-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights

G. Spyroulias, P. Cordopatis, M. Fragiadaki, 2010, Amino Acids.

Ethanol effects on striatal dopamine receptor-coupled adenylate cyclase and on striatal opiate receptors

B. Tabakoff, P. Hoffman, P. Cordopatis, 1983, Pharmacology Biochemistry and Behavior.

Synthesis and Biological Evaluation of New CRH Analogues

Jean Martinez, G. Spyroulias, P. Cordopatis, 2010, Bioinorganic chemistry and applications.

Gonadotropin-releasing hormone analogues alter gene expression of metalloproteinases and their tissue inhibitors in human breast cancer epithelial cells.

N. Karamanos, P. Cordopatis, F. Lamari, 2006, Anticancer research.

Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.

J. Manuguerra, I. Vergnon, P. Cordopatis, 1997, Journal of immunology.

Xanthones in Heterocyclic Synthesis. An Efficient and General Route for the Synthesis of Regioselectively Substituted Phthalazines.

C. Potamitis, M. Zervou, P. Cordopatis, 2011 .

XANTHONES IN HETEROCYCLIC SYNTHESIS. AN EFFICIENT ROUTE FOR THE SYNTHESIS OF C-3 o-HYDROXYARYL SUBSTITUTED 1,2-BENZISOXAZOLES AND THEIR N-OXIDES, POTENTIAL SCAFFOLDS FOR ANGIOTENSIN(II) ANTAGONIST HYBRID PEPTIDES

C. Potamitis, M. Zervou, P. Cordopatis, 2011 .

Xanthone in synthesis: a reactivity profile via directed lithiation of its dimethyl ketal

G. Varvounis, P. Cordopatis, P. G. Tsoungas, 2009 .

Dipeptides containing the alpha-aminoisobutyric residue (Aib) as ligands: preparation, spectroscopic studies and crystal structures of copper(II) complexes with H-Aib-X-OH (X=Gly, L-Leu, L-Phe).

A. Terzis, C. Raptopoulou, P. Cordopatis, 2003, Journal of inorganic biochemistry.

Reactions of 3d-metal nitrates with N,N′-bis(2-pyridyl)urea (LH2): preparation, X-ray crystal structures and spectroscopic studies of the products trans-[M(II)(ONO2)2(LH2)2] (M=Mn, Fe, Co, Ni, Cu, Zn) and mer-[Co(III)(LH)2](NO3)·MeOH

A. Terzis, C. Raptopoulou, P. Cordopatis, 2001 .

Synthesis, structural study and topological analysis of Zn/Aib and Aib-based small peptide complexes (H-Aib-OH = α-aminoisobutyric acid)

C. Raptopoulou, P. Cordopatis, K. Konidaris, 2009 .

Anionic ortho-FriesRearrangement, a Facile Route to Arenol-Based Mannich Bases

G. Stavropoulos, N. Assimomytis, G. Varvounis, 2009 .

Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).

A. Terzis, C. Raptopoulou, A. Pantazaki, 2008, Journal of inorganic biochemistry.

The dipeptide H-Aib-l-Ala-OH ligand in copper(II) chemistry: Variation of product identity as a function of pH

A. Terzis, C. Raptopoulou, P. Cordopatis, 2005 .

Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme

Georgios A. Dalkas, Jean Martínez, D. Marchand, 2010, Journal of peptide science : an official publication of the European Peptide Society.

Interaction of Cu(II) and Ni(II) with the 63-93 fragment of histone H2B.

I. Sóvágó, Csilla Kállay, P. Cordopatis, 2008, Dalton transactions.

Sulphonamide-based bombesin prodrug analogues for glutathione transferase, useful in targeted cancer chemotherapy.

Y. Clonis, N. Labrou, C. Petrou, 2009, European journal of medicinal chemistry.

Xanthones in Heterocyclic Synthesis. An Efficient Route for the Synthesis of C-3 o-Hydroxyaryl Substituted 1,2-Benzoisoxazoles and Their N-Oxides, Potential Scaffolds for Angiotensin(II) Antagonist Hybrid Peptides.

C. Potamitis, M. Zervou, P. Cordopatis, 2011 .

Xanthone in Synthesis: A Reactivity Profile via Directed Lithiation of Its Dimethyl Ketal.

G. Varvounis, P. Cordopatis, P. G. Tsoungas, 2010 .

Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.

G. Moore, J. Matsoukas, P. Cordopatis, 2009, International journal of peptide and protein research.

Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.

G. Spyroulias, P. Cordopatis, F. Lamari, 2011, Biopolymers.

Self‐association and solubility of peptides: Solvent‐titration study of Nα‐protected C‐terminal sequences of substance P

C. Toniolo, G. Bonora, G. Bonora, 1986, Biopolymers.

On the molecular basis of the recognition of angiotensin II (AII). NMR structure of AII in solution compared with the X-ray structure of AII bound to the mAb Fab131.

A. Bonvin, N. V. van Nuland, P. Cordopatis, 2003, European journal of biochemistry.

Comparison of the solution structures of angiotensin I & II. Implication for structure-function relationship.

Georgios A Spyroulias, Evy Manessi-Zoupa, G. Spyroulias, 2003, European journal of biochemistry.

Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity

D. Klimis-Zacas, P. Cordopatis, F. Lamari, 2009, Behavioural Brain Research.

Wild blueberry (Vaccinium angustifolium) consumption affects the composition and structure of glycosaminoglycans in Sprague-Dawley rat aorta.

A. Theocharis, D. Klimis-Zacas, P. Cordopatis, 2006, The Journal of nutritional biochemistry.

Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents.

M. Polissiou, P. Cordopatis, F. Lamari, 2006, Journal of agricultural and food chemistry.

Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.

C. Gilon, M. Chorev, P. Cordopatis, 2009, International journal of peptide and protein research.

Helicobacter pylori neutrophil‐activating protein activates neutrophils by its C‐terminal region even without dodecamer formation, which is a prerequisite for DNA protection – novel approaches against Helicobacter pylori inflammation

T. Choli-Papadopoulou, P. Cordopatis, F. Kottakis, 2008, The FEBS journal.

A peptide corresponding to the C‐terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro

E. Papadimitriou, G. Spyroulias, P. Cordopatis, 2011, Journal of cellular biochemistry.

Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.

P. Cordopatis, M. Fragiadaki, J. Slaninová, 2007, European journal of medicinal chemistry.

Structural studies with weak oxytocin antagonists

N. Assimomytis, P. Cordopatis, J. Slaninová, 1996, Letters in Peptide Science.

Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice

M. Oka, S. Takao, Ryouichi Tsunedomi, 2015, Cancer biology & therapy.

Synthesis of [1-Aib]-angiotensin II, an analogue with higher potency than [1-Asn,5-Val]-angiotensin II

P. Cordopatis, D. Theodoropoulos, 1983, Experientia.

Synthesis and pharmacological properties of [1-N4-dimethyl-asparagine]-angiotensin II

P. Cordopatis, J. Dirkx, D. Theodoropoulos, 1979, Experientia.

Methylation in positions 1 and 7 of angiotensin II. A structure-activity relationship study.

E. Escher, R. Bouley, P. Cordopatis, 2009, International journal of peptide and protein research.

Thyroxine-Binding Antibodies Inhibit T Cell Recognition of a Pathogenic Thyroglobulin Epitope1

P. Lymberi, P. Cordopatis, P. Eliades, 2005, The Journal of Immunology.

Analysis of the CD2 and spliceosomal Sm B/B′ polyproline‐arginine motifs defined by a monoclonal antibody using a phage‐displayed random peptide library

Malek Kamoun, Dimitri Monos, D. Monos, 2006, Journal of molecular recognition : JMR.

Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases.

G. Spyroulias, A. Galanis, P. Cordopatis, 2004, Current topics in medicinal chemistry.

Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β

Christos C. Petrou, M. Alexis, D. Mitsiou, 2011, Steroids.

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.

V. Georgoulias, D. Mavroudis, P. Cordopatis, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.

D. Mavroudis, V. Georgoulias, A. Galanis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Study of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Malignancies

I. Miconnet, P. Kanellou, M. Spyropoulou, 2006, Oncology.

Synthetic Peptides as Structural Maquettes of Angiotensin-I Converting Enzyme Catalytic Sites

G. Spyroulias, A. Galanis, P. Cordopatis, 2010, Bioinorganic chemistry and applications.

Folding in solution of the C‐catalytic protein fragment of angiotensin‐converting enzyme

L. Leondiadis, G. Spyroulias, P. Cordopatis, 2009, Journal of peptide science : an official publication of the European Peptide Society.

Expression, purification, and physicochemical characterization of the N‐terminal active site of human angiotensin‐I converting enzyme

L. Leondiadis, P. Cordopatis, G. Pairas, 2007, Journal of peptide science : an official publication of the European Peptide Society.

Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.

P. Cordopatis, R. Walter, C. W. Smith, 1980, Journal of medicinal chemistry.

Crocetin Inhibits Invasiveness of MDA‐MB‐231 Breast Cancer Cells via Downregulation of Matrix Metalloproteinases

P. Cordopatis, F. Lamari, Dimitra G. Chryssanthi, 2010, Planta medica.

Protection against lethal viral infection by vaccination with nonimmunodominant peptides.

J. Manuguerra, I. Vergnon, P. Cordopatis, 1996, Journal of immunology.

Synthetic peptides from the IL-2Rβ sequence (30–54) affect interleukin-2 (IL-2) binding

V. Georgoulias, G. Sotiropoulou, P. Cordopatis, 1993 .

emory enhancing effects of saffron in aged mice are correlated with ntioxidant protection agdalini

P. Cordopatis, A. Papandreoua, Maria Tsachakib, 2011 .

[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.

B. Bernard, E. Krenning, W. Breeman, 2006, European journal of nuclear medicine and molecular imaging.

Synthetic peptides as putative therapeutic agents in transplantation medicine: application of PEPSCAN to the identification of functional sequences in the extracellular domain of the interleukin-2 receptor beta chain (IL-2Rbeta).

R. Meloen, G. Sotiropoulou, A. Mouzaki, 2000, Journal of immunological methods.

Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.

Athanasios Papakyriakou, Georgios A Spyroulias, Evy Manessi-Zoupa, 2007, Biochemistry.

Structural studies of “aggregation‐prone” peptide‐analogues of teleostean egg chorion ZPB proteins

Nikolaos N. Louros, S. Hamodrakas, V. Iconomidou, 2014, Biopolymers.

Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family.

Andreas Hoenger, Stavros J Hamodrakas, Vassiliki A Iconomidou, 2006, Journal of structural biology.

MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1.

J. Parry, B. Rogers, B. Nock, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on breast cancer cells†

B. Nock, T. Maina, A. Nikolopoulou, 2008 .

Synthesis and Biological Evaluation of New GnRH Analogues on Pituitary and Breast Cancer Cells

G. Spyroulias, B. Nock, T. Maina, 2007, International Journal of Peptide Research and Therapeutics.

Solid‐phase synthesis and conformational properties of angiotensin converting enzyme catalytic‐site peptides: The basis for a structural study on the enzyme–substrate interaction

G. Spyroulias, A. Galanis, P. Cordopatis, 2004, Biopolymers.

Zinc binding in peptide models of angiotensin‐I converting enzyme active sites studied through 1H‐NMR and chemical shift perturbation mapping

R. Pierattelli, G. Spyroulias, A. Galanis, 2003, Biopolymers.

Synthesis and biological activities of [β-malyl1]- and [β-Malyl1, Leu8]-angiotensin II analogues

J. Matsoukas, P. Cordopatis, D. Theodoropoulos, 1983, Experientia.

Electronic Sculpting of Ligand-GPCR Subtype Selectivity: The Case of Angiotensin II

T. Crook, J. Selent, M. Tamura, 2014, ACS chemical biology.

Current Inhibition Concepts of Zinc Metallopeptidases Involved in Blood Pressure Regulation

G. Spyroulias, P. Cordopatis, 2005 .

NMR Conformational Analysis of LHRH and its analogues

P. Cordopatis, G. Spyroulias, Aikaterini A Zompra, 2006 .

Structural studies and cytotoxicity assays of “aggregation‐prone” IAPP8–16 and its non‐amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin

Nikolaos N. Louros, S. Hamodrakas, I. Trougakos, 2015, Biopolymers.

Conformational analysis of the nonapeptide leuprorelin using NMR and molecular modeling

D. Benaki, E. Mikros, P. Cordopatis, 2001, Letters in Peptide Science.

Synthesis of L-prolyl-L-leucylglycine alkylamides.

J. Matsoukas, P. Cordopatis, D. Theodoropoulos, 1977, Journal of Organic Chemistry.

Synthesis and proposed conformations of l-prolyl-l-leucyl-β-alanine alkylamides

J. Matsoukas, P. Cordopatis, G. Stavropoulos, 1978 .

The silkmoth eggshell as a natural amyloid shield for the safe development of insect oocyte and embryo: Insights from studies of silkmoth chorion protein peptide‐analogues of the B famil

S. Hamodrakas, A. Hoenger, V. Iconomidou, 2011, Biopolymers.

Tetraamine‐modified octreotide and octreotate: labeling with 99mTc and preclinical comparison in AR4‐2J cells and AR4‐2J tumor‐bearing mice

B. Nock, T. Maina, A. Nikolopoulou, 2006, Journal of peptide science : an official publication of the European Peptide Society.

Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.

G. Moore, J. Matsoukas, P. Cordopatis, 1988, Journal of medicinal chemistry.

Angiotensin II Analogues with Sulphur-containing Side-chains in Position 5

E. Escher, R. Bouley, P. Cordopatis, 2000, Arzneimittelforschung.

Modifications in positions 3 and 5 of angiotensin II

E. Escher, N. Assimomytis, R. Bouley, 1995 .

The influence of certain substitutions on 1 and 2 positions of angiotensin II on biological responses

E. Escher, P. Cordopatis, R. Bossé, 1988 .

Synthesis of histidine2-angiotensin II analogues

P. Cordopatis, D. Theodoropoulos, 1975, Experientia.

Plasma levels of endothelin and early carotid atherosclerosis in diabetic patients.

K. Karmaniolas, P. Cordopatis, I. Migdalis, 2000, Research communications in molecular pathology and pharmacology.

Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.

Georgios A Spyroulias, Evy Manessi-Zoupa, G. Spyroulias, 2003, Protein engineering.

Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties.

A. Furst, T. Lee, E. Escher, 1985, Journal of medicinal chemistry.

The European Peptide Society Newsletter

P. Cordopatis, 2023, Journal of Peptide Science.

Progression of carotid atherosclerosis and the role of endothelin in diabetic patients.

K. Karmaniolas, P. Cordopatis, I. Migdalis, 2000, Research Communications in Molecular Pathology and Pharmacology.

Changes in residues 1 and 4 of angiotensin II affect differently its agonist and tachyphylactic properties

C. Nakaie, P. Cordopatis, A. Paiva, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β

Christos C. Petrou, M. Alexis, D. Mitsiou, 2011, Steroids.

Glutathione analogues as substrates or inhibitors that discriminate between allozymes of the MDR‐involved human glutathione transferase P1‐1

T. Thireou, Y. Clonis, E. Eliopoulos, 2016, Biopolymers.

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile

B. Nock, T. Maina, P. Cordopatis, 2024, International journal of molecular sciences.

3D solution structure of [Tyr3]octreotate derivatives in DMSO: structure differentiation of peptide core due to chelate group attachment and biologically active conformation.

G. Spyroulias, B. Nock, T. Maina, 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).